Karin Nielsen-Saines, MD
Total Page:16
File Type:pdf, Size:1020Kb
August 21, 2020 Karin Nielsen-Saines, M.D., M.P.H Curriculum Vitae I. PERSONAL HISTORY Business Address: Mattel Children's Hospital at UCLA Division of Pediatric Infectious Diseases David Geffen UCLA School of Medicine MDCC 22-442 10833 LeConte Ave. Los Angeles, CA 90095 Tel: 310 - 206-6640 FAX: 310 - 825-9175 [email protected] 1 August 21, 2020 II. EDUCATION Secondary School: Our Lady of Mercy High School Rio de Janeiro, Brazil 1975- 1979 Valedictorian Class of 1979 Medical School: Universidade do Rio de Janeiro (Uni-Rio) Escola de Medicina e Cirurgia Rio de Janeiro, Brazil 1980 – 1986 Valedictorian Class of 1986 Pediatric Residency: Department of Pediatrics Hospital dos Servidores do Estado do Rio de Janeiro Rio de Janeiro, Brazil 1986 - 1989 Postdoctoral Fellowship: Pediatric Infectious Diseases (Clinical and Research) Department of Pediatrics UCLA School of Medicine Los Angeles, CA 1991 – 1996 Masters Degree: Public Health, Field of study: Epidemiology UCLA School of Public Health Los Angeles, CA 1993- 1994 III. LICENSURE: CRM 52 48.185-1 (Rio de Janeiro, Brazil) A064837 (California, USA) DEA # BN5830143 ECFMG certificate: 0-458-475-1 IV. BOARDS/ CERTIFICATION Brazilian Board of Pediatrics (Sociedade Brasileira de Pediatria/ Título de Especialista) Pediatric Board Exams, Rio de Janeiro, Brazil , April 1989 United States Medical Boards: USMLE Part 1 June 1995, USMLE Part 2 March 1995, USMLE Part 3 December 1995 American Academy of HIV Medicine (AAHIVM) Certified HIV Medicine Specialist- certifying exam 9/29/12, 9/30/14 2 August 21, 2020 V. PROFESSIONAL EXPERIENCE Positions Held: July 1989 – June 1991 Attending Pediatrician Rio de Janeiro State Health Department July 1991 – June 1996 Postdoctoral fellow Pediatric Infectious Diseases Department of Pediatrics UCLA School of Medicine July 1996 – June 1999 Clinical Instructor (Health Sciences Series) Pediatric Infectious Diseases Department of Pediatrics UCLA Mattel Children's Hospital July 1999 – June 2004 Assistant Clinical Professor (Health Sciences Series) Pediatric Infectious Diseases Department of Pediatrics UCLA Mattel Children's Hospital July 2004 – June 2010 Associate Clinical Professor (Health Sciences Series) Pediatric Infectious Diseases Department of Pediatrics UCLA Mattel Children’s Hospital July 2010 – June 2013 Clinical Professor (Health Sciences Series) Pediatric Infectious Diseases Department of Pediatrics UCLA Mattel Children’s Hospital July 2013 – June 2019 Professor of Clinical Pediatrics (Professor X series) Pediatric Infectious Diseases Department of Pediatrics UCLA Mattel Children’s Hospital Present Position: Professor of Pediatrics (In residence series) July 2019 – Present Pediatric Infectious Diseases Department of Pediatrics UCLA Mattel Children’s Hospital 3 August 21, 2020 VI. Professional Activities A. UCLA (Committees/ teaching/ medical activities) 1. Member: UCLA Medical Center Hospital Infection Control Committee since 1996 2. Attending Physician UCLA Children’s Hospital since 1996 3. Co-Director and Attending Physician Care 4 Families Clinic UCLA since 1996 4. Faculty of the UCLA Doctoring Program 2 1996-1999 5. Core Lecturer Core Seminars Pediatrics/ Medical Pediatric Clerkship since 1996 6. Speaker Resident Noon Conferences since 1996 7. Speaker Pediatric Infectious Diseases Divisional Conferences since 1996 8. Lecturer UCLA Pediatric Board Reviews Course 1997- to present 9. Core Lecturer UCLA Microbiology and Immunology 201 Graduate Course since 1998 10. Core Lecturer M228 Biology of HIV Graduate Course since 2002 11. DPGP Board UCLA (elected member) 2004 – 2009 12. UCLA AIDS Institute Co-chair Novel Therapies Area since 2007 13. UCLA AIDS Institute Steering Committee since 2009 14. UCLA Center for Brazilian Studies Faculty Advisory Committee since 7/ 2009 15. UCLA Medical Institutional Review Board Committee Member-MIRB-2 since 7/ 2010 16. Director, UCLA Center for Brazilian studies since 9/ 2012 17. Co-Chair, UCLA International Institute- UCLA- Brazil Executive Committee 9/2012 18. Search Committee Vice-Provost for International Initiatives, UCLA International Institute, 2013 19. Task force- curricular development for Brazilian medical students coming to UCLA through the Brazilian Scientific Mobility Program, University Extension (UNEX) and the David Geffen School of Medicine at UCLA, since 2013 20. David Geffen School of Medicine (DGSOM) theme leader/ clinical partner in a task force for evaluation of NIH funding, clinical excellence and opportunities for future investment and growth. Member of the Immunology, Inflammation and Infectious Disease (I3T) team, since 2013. 21. Program Evaluation Committee (PEC)- UCLA Ped Inf Diseases Fellowship Program, since 2013 22. Associate Director, Global Ped Infectious Diseases Fellowship Program at UCLA, since 2015 23. DPGP Board UCLA (elected member) 2015- to present 24. Search Committee, Deparment of Pediatrics, Division Chief for Endocrinology 2016-17 25. Search Committee, Deparment of Pediatrics, Nephrology Transplant Program Director 2016-17 26. Pediatric Grand Rounds Committee, Department of Pediatrics, 2013- 2017 27. CDI Grant Review Program, Department of Pediatrics, September 2016, November 2017 28. Faculty and Mentor to the UCLA DGSOM Saphir International Scholars Program 2013-ongoing 29. Search Committee, Department of Pediatrics, Division Chief for General Pediatrics 2019 30. Search Committee Head, Dept Pediatrics, Division Chief for Pediatric Hospitalist Division 2020 31. Search Committee Head, Dept of Pediatrics, Division Chief for General Pediatrics 2020 B. Membership in Medical Societies: 1. Member: Brazilian Society of Pediatrics- since 1989 4 August 21, 2020 2. Member: Pediatric Infectious Disease Society- since 1996 3. Member: American Academy of Pediatrics, Committee of AIDS, California Ch 2- since1997 4. Honorary member: Brazilian Society of Pediatric Infectious Diseases- since 1998 5. Elected member: Society for Pediatric Research- since 1999 6. Member: Brazilian Society of Infectious Diseases- since 1999 7. Member: International AIDS Society (IAS)- since 2002 8. Member: American Academy of HIV Medicine (AAHIVM)- since 2012 9. Elected Member: American Pediatric Society (APS)- since 2013 10. Elected Member: Diaspora Network Brazil- since 2015 11. Elected Member: American Epidemiological Society- since 2019 C. National and International Medical/ Governmental Societies/ Networks: 1. NIH/ Pediatric AIDS Clinical Trials Group/ PACTG (1999-2006) • Elected member: PACTG: Perinatal Research Agenda Committee (RAC)1999-2006 • Vice- Chair: PACTG: Perinatal Research Agenda Committee (RAC) 2003-06 2. NIH/ HIV Prevention Trials Network/ HPTN (2000-2006): • Member: HIV Prevention Trials Network HPTN, Microbicide Committee 2000-06 • Member: HIV Prevention Trials Network HPTN, Perinatal Working Group 2000-06 3. NIH/ Adult AIDS Clinical Trials Group/ AACTG (2002-ongoing): • Member of the AACTG, Protocol Chair and investigator in studies, 2002-present 4. NIH/ International Maternal Pediatric Adolescent AIDS Clinical Trials IMPAACT (2005-ongoing) • Elected: IMPAACT Scientific Leadership: Scientific Oversight Committee (SOC) international member at large for the NIAID, 6/2006- 5/2009 (3 year term) • Elected: IMPAACT Executive Leadership NIH: Network Executive Committee (NEC) international member at large for the NIAID, 6/2009-5/2014 (5 year term). • Elected member: International Resource Committee: IMPAACT network. • Elected member: IMPAACT Tuberculosis Scientific Committee, 12/2011- 5/2014. 5. NIH/ Adolescent Trials Network ATN (2016 -ongoing) D1. Clinical Trial Responsibilities. NIH: 1. Protocol chair: ATN CARES 147 (Adolescent Trials Network): Comprehensive Adolescent Recruitment and Engagement Services; Acute HIV Infection in Youth. Study ongoing. 2. Capsule chair: IMPAACT CAPSULE 542: Acceptability and Feasibility of Breastfeeding in HIV- infected women with full HIV virological suppression in mid-developed/ developed settings. Capsule submitted for protocol development. 3. Protocol Co-Chair: HPTN 052: A Randomized Trial to Evaluate the Effectiveness of Antiretroviral Therapy plus HIV Primary Care versus HIV Primary Care Alone to Prevent the Sexual Transmission of HIV-1 in Serodiscordant Couples. Study completed 10/ 2015. Data analysis ongoing. 1. Chair HPTN 052 Substudy: Pregnancy Outcomes in HPTN 052. Data analysis ongoing. 5 August 21, 2020 2. Protocol Chair: NICHD/ HPTN 040/ PACTG 1043: Randomized Neonatal Antiretroviral Post- Exposure Prophylaxis Clinical Trial. Study completed in 12/2014. Data analysis ongoing 3. Protocol Co-Chair: AACTG 5190/ PACTG 1054: Assessment of Safety and Toxicity Among Infants Born to HIV-1 Infected Women Enrolled in Antiretroviral Treatment Protocols in Diverse Areas of the World- Study completed in 2011. Data analysis completed. 4. Investigator: DACS 303 ACTG. Pregnancy predictors and outcomes for women in Resource Limited Settings: Cross protocol Analysis of 5208, 5175 and HPTN 052. Data analysis completed. 5. Protocol Team Investigator PROMISE - Promoting Maternal Infant Survival Everywhere. HIV-1 Late Presenters Section. Data analysis ongoing 6. Protocol Team Investigator PACTG 1025- Pediatric HIV Pregnancy Cohort. Data analysis ongoing 7. Protocol Team Investigator: Protocol Team HPTN 057: A Phase I Open Label Trial of the Safety and Pharmacokinetics of Tenofovir Disoproxil Fumarate in HIV-1 Infected Pregnant Women and their Infants. Study completed. Final publication published in 1/2016. 8. Protocol Team Investigator: AACTG A5175: A Phase III,